ScinoPharm Taiwan, Ltd. (TPE:1789)

ScinoPharm Taiwan Revenue

ScinoPharm Taiwan had revenue of 721.50M TWD in the quarter ending September 30, 2025, a decrease of -0.38%. This brings the company's revenue in the last twelve months to 3.19B, down -8.62% year-over-year. In the year 2024, ScinoPharm Taiwan had annual revenue of 3.41B with 6.91% growth.

• Revenue (ttm): 3.19B
• Revenue Growth: -8.62%
• P/S Ratio: 4.40
• Revenue / Employee: 5.91M
• Employees: 540
• Market Cap: 14.04B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.41B	220.20M	6.91%
Dec 31, 2023	3.19B	-77.96M	-2.39%
Dec 31, 2022	3.26B	501.71M	18.16%
Dec 31, 2021	2.76B	-320.59M	-10.40%
Dec 31, 2020	3.08B	190.15M	6.57%